ACEi, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; BMI, body mass index in kg/m2; BP, blood pressure; Behavioral intervention; CCB, calcium channel blocker; CHP, Cardiovascular Health Program; CIMT, carotid intima-media thickness; CLIA, Clinical Laboratory Improvement Amendments; Cardiovascular disease; Cardiovascular risk; DPP4, mdipeptidyl peptidase 4 inhibitor; Dias BP, diastolic blood pressure in mm Hg; ESS, Epworth Sleepiness Scale; FBG, fasting blood glucose in mg/dL; HOMA-IR, homeostatic model assessment for insulin resistance; IPAQ, International Physical Activity Questionnaire; IRB, institutional review board; LDL, low density lipoprotein; MACE, major adverse cardiovascular events; NDRI, nicotine and dopamine reuptake inhibitor; NP, nurse practitioner; PSQI, Pittsburgh Sleep Quality Index; PSS, Perceived Stress Scale; Prevention; RYP, Rate-Your-Plate; SARI, serotonin antagonist and reuptake inhibitor; SD, standard deviation; SNRI, serotonin-norepinephrine reuptake inhibitor; SPSS, Statistical Package for the Social Science; SSRI, selective serotonin reuptake inhibitor; Statin, HMG-CoA reductase inhibitor; Sys BP, systolic blood pressure in mm Hg; TCA, tricyclic antidepressant; TLC, therapeutic lifestyle change; Therapeutic lifestyle change; Tot Chol, total cholesterol in mg/dL; Trig, triglycerides in mg/dL; WC, waist circumference in cm; α Blocker, alpha blocker; ß blocker, beta blocker